Researchers conducted a post hoc analysis to compare the performance of 2 disease activity scores — BASDAI and ASDAS — in assessing axial involvement in patients with PsA receiving treatment with guselkumab.

The safety and efficacy of deucravacitinib in active SLE was assessed in a randomized placebo-controlled trial presented at ACR Convergence 2022.

Researchers studied the prevalence of heel enthesitis in axial spondyloarthritis and assessed its impact on outcome measures after a 2-year follow-up.

Researchers described the obstetric outcomes, based on COVID-19 vaccination status, in pregnant women with rheumatic and musculoskeletal diseases.

The role of micro-RNAs in the pathophysiology of hand osteoarthritis was explored, using data from postmenopausal women.

Presenting at ACR 2022, researchers assessed the safety and efficacy of pegloticase with add-on methotrexate vs placebo for uncontrolled gout.

A post hoc analysis was conducted to compare the risk for cardiovascular events between treatment with tofacitinib and TNF inhibitors among patients with RA.

Researchers assessed the risks and benefits of glucocorticoids in women with inflammatory rheumatic musculoskeletal diseases.

Using the DANBIO registry, the effectiveness of infliximab biosimilar switching was assessed among patients with inflammatory arthritis.

The aim of the study was to evaluate the effect of the Roe v Wade decision on methotrexate access among patients with rheumatic disease.

Researchers conducted a head-to-head trial that compared the effect of secukinumab and adalimumab biosimilar on spinal radiographic progression in axial spondyloarthritis.

Researchers assessed the effect of tapering of corticosteroids or immunosuppressive therapy on disease activity, flare rate, and remission among patients with stable systemic lupus erythematosus.

Researchers conducted a post hoc analysis to determine the effect of early response to upadacitinib on long-term clinical outcomes in rheumatoid arthritis.

The TICOG study was conducted to compare monthly urate-lowering therapy titration and conventional treatment in achieving and maintaining optimal serum uric acid levels in gout.

Using data from the National Inpatient Sample, the association between systemic vasculitis and myocardial infarction was reported.

Study investigators compared the effectiveness of 3 consensus treatment plans to achieve clinically inactive disease in patients with untreated polyarticular juvenile idiopathic arthritis (pJIA).

Researchers assessed the efficacy of rituximab and cyclophosphamide in the treatment of mixed connective tissue disease-related interstitial lung disease.

Researchers presented a gout genome-wide association study (GWAS) to identify genes and pathways that enable the progression of hyperuricemia to gout.

In a phase 3 trial, researchers studied the safety and efficacy of sarilumab among patients with relapsing polymyalgia rheumatica.

Researchers determined the effect of a weight loss and exercise program on knee pain among patients with knee osteoarthritis, overweight, and obesity.